WAVE Life Sciences Ltd Stock
WAVE Life Sciences Ltd Stock
A very strong showing by WAVE Life Sciences Ltd today, with an increase of €0.25 (4.550%) compared to yesterday's price.
WAVE Life Sciences Ltd is currently one of the favorites of our community with 8 Buy predictions and no Sell predictions.
As a result the target price of 9 € shows a very positive potential of 57.89% compared to the current price of 5.7 € for WAVE Life Sciences Ltd.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for WAVE Life Sciences Ltd stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of WAVE Life Sciences Ltd in the next few years
Pros
?
M***** P*******
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of WAVE Life Sciences Ltd vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
WAVE Life Sciences Ltd | 4.550% | 28.378% | -1.724% | 57.459% | 24.454% | 8.530% | - |
Chromadex Corp | 1.810% | 8.696% | 4.790% | 180.000% | 161.194% | -51.724% | - |
Organovo Holdings Inc. | 10.940% | 2.872% | 1.363% | -43.118% | -5.750% | -85.556% | -94.698% |
Intellia Therapeutics Inc | 1.470% | 13.026% | -5.028% | -37.275% | -24.318% | -64.164% | 62.236% |
Comments
Wave Life Sciences Ltd. (NASDAQ: WVE) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $17.00 price target on the stock.
Show more
Ratings data for WVE provided by MarketBeat
Wave Life Sciences Ltd. (NASDAQ: WVE) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Show more
Ratings data for WVE provided by MarketBeat
Wave Life Sciences Ltd. (NASDAQ: WVE) was upgraded by analysts at Leerink Partnrs from a "market perform" rating to an "outperform" rating.
Show more
Ratings data for WVE provided by MarketBeat